Potassium ion-induced swelling of nerve-ending particles by light-scattering measurement.
D000818:Animals; D002118:Calcium / Q000494:pharmacology; D002499:Centrifugation, Density Gradient; D002540:Cerebral Cortex / Q000166:cytology; D002586:Cesium / Q000494:pharmacology; D002614:Chelating Agents / Q000494:pharmacology; D005033:Ethylmaleimide / Q000494:pharmacology; D005260:Female; D066298:In Vitro Techniques; D008094:Lithium / Q000494:pharmacology; D008297:Male; D009411:Nerve Endings / Q000187:drug effects*; D009994:Osmolar Concentration; D009995:Osmosis; D010042:Ouabain / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology*; D011189:Potassium Chloride / Q000494:pharmacology; D051381:Rats; D012413:Rubidium / Q000494:pharmacology; D012542:Scattering, Radiation; D012965:Sodium Chloride / Q000494:pharmacology; D014461:Ultracentrifugation
D002614:Chelating Agents; D002586:Cesium; D012965:Sodium Chloride; D010042:Ouabain; D011189:Potassium Chloride; D008094:Lithium; D012413:Rubidium; D005033:Ethylmaleimide; D011188:Potassium; D002118:Calcium